9Y2.F LABOCANNA S.A. ZY-10
- Market cap
- EUR 890K
- P/E
- -
- P/B
- 1.38x
- ROE
- -287.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 9Y2.F undervalued?
Graham numberThe Graham number of LABOCANNA S.A. ZY-10 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LABOCANNA S.A. ZY-10 fundamental analysis
No fundamental analysis for LABOCANNA S.A. ZY-10 yet.
LABOCANNA S.A. ZY-10 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. It is also involved in commercial real estate management activities. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. Labocanna S.A. was incorporated in 2011 …
Full company profileLABOCANNA S.A. ZY-10 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
LABOCANNA S.A. ZY-10 annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 2.93K | 16.5K | 1.01M | 2.24M | 4.80K |
| Gross Profit | -20.4K | -5.06K | 211K | 398K | -6.56K |
| Operating Income | -129K | -413K | -105K | -173K | -414K |
| EBITDA | -979K | -268K | -277K | -229K | -6.76M |
| Net Income | -1.19M | -599K | -442K | -873K | -8.07M |
| EPS | -0.06 | -0.03 | -0.02 | -0.04 | -0.38 |
| Balance Sheet | |||||
| Total Assets | 8.79M | 7.56M | 8.39M | 13.5M | 9.53M |
| Total Liabilities | 1.19M | 548K | 1.80M | 7.75M | 6.70M |
| Shareholders' Equity | 7.61M | 7.01M | 6.57M | 5.70M | 2.81M |
| Cash & Short-term Investments | 2.05M | 894K | 149K | 379K | - |
| Cash Flow | |||||
| Operating Cash Flow | -286K | -1.08M | -901K | -971K | -1.58M |
| Capital Expenditure | 1.08M | 1.07M | 324K | 96.4K | 1.12M |
| Free Cash Flow | -1.37M | -2.15M | -1.22M | -1.07M | -2.70M |
| Ratios | |||||
| ROE | -15.6% | -8.5% | -6.7% | -15.3% | -287.2% |
| ROA | -13.5% | -7.9% | -5.3% | -6.5% | -84.6% |
| Net Profit Margin | -40,428.7% | -3,624.5% | -43.7% | -38.9% | -168,032.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
LABOCANNA S.A. ZY-10 dividends
LABOCANNA S.A. ZY-10 has not paid dividends in the last 4 fiscal years.
Who owns LABOCANNA S.A. ZY-10
- Insiders 10.22%
- Institutions 0.00%
- Public & others 89.78%
- Shares outstanding 21.2M
- Free float 19.0M
LABOCANNA S.A. ZY-10 company profile
- Company name
- LABOCANNA S.A. ZY-10
- Ticker
- 9Y2.F
- ISIN
- PLCCTLS00017
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Employees
- 3
- Fiscal year end
- December
- Address
- ul.Mieszka149, Koszalin, Poland, 75-126
- Website
- labocanna.pl
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. It is also involved in commercial real estate management activities. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. Labocanna S.A. was incorporated in 2011 and is headquartered in Koszalin, Poland.
LABOCANNA S.A. ZY-10 management
1- Mr. Pawel KicinskiPresident of the Management Board